TQCYX
Price
$19.42
Change
+$0.13 (+0.67%)
Updated
Oct 4 closing price
VVIAX
Price
$68.12
Change
+$0.53 (+0.78%)
Updated
Oct 4 closing price
Ad is loading...

TQCYX vs VVIAX

Header iconTQCYX vs VVIAX Comparison
Open Charts TQCYX vs VVIAXBanner chart's image
Touchstone Dividend Equity Y
Price$19.42
Change+$0.13 (+0.67%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$68.12
Change+$0.53 (+0.78%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TQCYX vs VVIAX Comparison Chart
Loading...
VS
TQCYX vs. VVIAX commentary
Oct 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TQCYX is a StrongBuy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 186B vs. TQCYX (2.5B). VVIAX (2.36) and TQCYX (2.25) have matching dividends . TQCYX was incepted earlier than VVIAX: TQCYX (11 years) vs VVIAX (24 years). TQCYX is a more actively managed with annual turnover of: 13.00 vs. VVIAX (10.00). TQCYX has a lower initial minimum investment than VVIAX: TQCYX (2500) vs VVIAX (3000). VVIAX (27.91) and TQCYX (27.33) have marching annual gain over last year. VVIAX return over 5 years is better than : 57.64 vs. TQCYX (29.74).
TQCYXVVIAXTQCYX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years24 years-
Gain YTD14.59316.01691%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.5B186B1%
Annual Yield % from dividends2.252.3696%
Returns for 1 year27.3327.9198%
Returns for 3 years19.4727.2371%
Returns for 5 years29.7457.6452%
Returns for 10 years42.75115.7537%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRT102.690.41
+0.40%
Vertiv Holdings Co
TH7.720.03
+0.39%
Target Hospitality Corp
SBT4.41N/A
N/A
Sterling Bancorp
RUSHB45.05-0.91
-1.98%
Rush Enterprises
DARE3.18-0.07
-2.15%
Dare Bioscience Inc.